The #CALIPSO randomized clinical trial showed that OCT guidance associated with predefined algorithmic management achieved better stent implantation results than angiography guidance in patients with calcified lesions PCI, without any safety concern.
https://t.co/rC0HNbMlsC
Are you interested in LM PCI and attending #EuroPCR ? We propose you a a simulation-based learning session using a new high-tech bench. Perfect & fun way to learn the principles of bifurcation PCI ! Tuesday 20/05 12:00 to 1 pm with @GoranEBC ,@nicolasamabile@M_Lesiak
Spotlight on Simulation-Based Learning!
At #PCRLV 2024, we were thrilled to welcome @nicolasamabile and @juliendjdj from ACTIF, a French congress built around simulation-based learning, dedicated to managing complications and mastering complex procedures in #interventionalcardiology.
Exciting news ahead: PCR and ACTIF will join forces in 2025 to launch international, innovative simulation-based training programs tailored for young cardiologists.
✨ Stay tuned for more!
#Sim1Do1Teach1
Another awesome Left main stenting simulation session on bench today with the master @olivierdarremont teaching the different techniques during @GRCIcardio meeting ! @BifurcationClub@GoranEBC@BSC_EU_Heart
A tough case of calcified distal LM & Medina 1-1-1 lesion in a 78 y-o man with recent MI related to postal RCA lesion (treated with PCI) & LVEF=45%. Different possible options when the 7 Fr EBU 3.75 Guiding catheter is engaged
🙌 #ACTIF2024 is live! A conference dedicated to simulation at the heart of education for interventional cardiology. Two days of exchange, 27 workshops, 11 rooms. Prepare for an immersive experience! #SimulationEducation#Innovation#Training@CongresActif
🎉 #ACTIF2024 c'est parti ! 🚀 4 parcours : Advanced, DJ Junior, DJ Senior, Paramed. La simulation au cœur de l'éducation. Deux jours d'échanges, 27 ateliers, 11 salles. Soyez prêts pour une expérience immersive ! #SimulationEducation#Innovation#Formation
77 y-o man, NSTEMI with hemodynamics instability Coronary angiography : occluded RCA + severe distal LM /LAD/ Cx lesion
Impella implantation + LAD & Cx predilation with 2.0 semi compliant balloon
What are the next steps ?
Nightmare in the cath lab 😱
The balloon gets stuck after post-dilation. It gets worse the shaft breaks when you try to pull the system out - you can't retrieve it, you can't snare it.
😨What would you do?
@jeroen_sonck @jcspratt@PCRonline
If PCI as a "therapy" for stable ischemic heart disease is controversial, its role as a "prevention" for vulnerable plaques is even more controversial.
In a few weeks, at ACC.24, the PREVENT investigators will present the results of a multicenter, open-label, randomized controlled trial comparing preventive PCI plus medical therapy versus medical therapy alone in more than 1,600 patients with functionally insignificant (fractional flow reserve >0.80) vulnerable plaques containing multiple high-risk features.
Anticipating the presentation and publication of PREVENT, we invited @dukwoo_park and @DavidLBrownMD to debate on prophylactic stenting of vulnerable plaques.
https://t.co/aPPOZBPemi
Randomized controlled trials are widely acknowledged as the primary method for producing robust evidence. Nevertheless, observational studies are frequently employed to assess intervention effectiveness in real-world settings. They offer insights into rare outcomes and long-term effects, are cost-effective, and provide more generalizable results. However, observational studies are prone to biases and confounding, which can be statistically assessed but may ultimately compromise the validity of findings. The role of observational studies in shaping evidence-based medicine remains a matter of debate.
https://t.co/PglBtfCjYy
So glad to finally share !
Computed Tomography Scan Evidence for Left Atrial Appendage Short‐Term Remodeling Following Percutaneous Occlusion: Impact of Device Oversizing | Journal of the American Heart Association https://t.co/n04Ob93ec4
📣Vous l'attendiez avec impatience, il est en ligne !
Le programme du #GRCI 2023 vient d'être dévoilé. 141 orateurs renommés, des LIVE, des ateliers pratiques, des "Live in-a-Box" et bien plus !
Nous avons hâte de vous retrouver à Paris du 13 au 15 décembre 2023🗓️ .
Un grand merci à tous les participants à cette première journée #Actif2023 !
Vos échanges enrichissants et votre présence ont apporté une valeur inestimable à cette journée. Merci d'avoir contribué à faire de cette journée exceptionnelle un véritable succès ! 🙏🌟